4//SEC Filing
BENITO SIMON X 4
Accession 0001055726-22-000025
CIK 0001055726other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:03 PM ET
Size
8.5 KB
Accession
0001055726-22-000025
Insider Transaction Report
Form 4
BENITO SIMON X
Director
Transactions
- Exercise/Conversion
Common Stock
2022-03-16$2.20/sh+2,000$4,400→ 59,305 total - Exercise/Conversion
Common Stock Options
2022-03-16−2,000→ 6,000 totalExercise: $2.20From: 2012-08-10Exp: 2022-08-10→ Common Stock (2,000 underlying) - Sale
Common Stock
2022-03-16$3.16/sh−2,000$6,320→ 57,305 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001273306
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:03 PM ET
- Size
- 8.5 KB